|
gptkbp:instanceOf
|
gptkb:antibiotic
|
|
gptkbp:administeredBy
|
oral
topical
intravenous
|
|
gptkbp:ATCCode
|
J01BA01
|
|
gptkbp:brand
|
gptkb:Chloromycetin
Chloromycetinum
|
|
gptkbp:CASNumber
|
56-75-7
|
|
gptkbp:chemicalFormula
|
C11H12Cl2N2O5
|
|
gptkbp:contraindication
|
pregnancy
neonates
|
|
gptkbp:discoveredBy
|
gptkb:David_Gottlieb
|
|
gptkbp:discoveredIn
|
1947
|
|
gptkbp:excretion
|
gptkb:kidney
|
|
gptkbp:hasSMILES
|
C1=CC(=CC=C1[C@@H]([C@@H](CO)O)NC(=O)C(Cl)Cl)[N+](=O)[O-]
|
|
gptkbp:hasUNII
|
362O9ITL9D
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Chloramphenicolum
|
|
gptkbp:IUPACName
|
2,2-dichloro-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)-2-(4-nitrophenyl)ethyl]acetamide
|
|
gptkbp:KEGGID
|
D00252
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:mechanismOfAction
|
inhibits bacterial protein synthesis
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:PubChem_CID
|
5959
17698
DB00446
|
|
gptkbp:sideEffect
|
gptkb:gray_baby_syndrome
aplastic anemia
bone marrow suppression
|
|
gptkbp:spectrumOfActivity
|
broad-spectrum
|
|
gptkbp:usedFor
|
bacterial infections
|
|
gptkbp:bfsParent
|
gptkb:D00222
|
|
gptkbp:bfsLayer
|
7
|